TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Conditions
- Hemophilia A
- Factor VIII (FVIII)
Interventions
- DRUG: Half-life factor VIII based replacement therapy
- DRUG: Non-FVIII based replacement therapy
Sponsor
University of Texas Southwestern Medical Center
Collaborators